Age and left ventricular hypertrophy (LVH) are major determinants of left ventricular (LV) diastolic dysfunction 1 and impaired autonomic activity assessed both at ...

The natural history of subclinical systolic and diastolic LV dysfunction in the general population is currently unknown. Serial imaging studies are required to clarify the progression of LV changes ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

Evaluation of NT-proBNP in patients may lead to early exclusion of Left Ventricular dysfunction, according to a new study. The value and cost-effectiveness of screening for left ventricular (LV) ...

Left ventricular diastolic dysfunction is associated with worse health status among patients with severe aortic stenosis, but TAVR leads to clinically meaningful symptomatic improvements regardless of ...

A new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were associated with improved left ...

Advanced left ventricular diastolic dysfunction (LVDD) in patients undergoing TAVR is linked with almost a fourfold increase in risk of postprocedural death as early as 30 days postprocedure, ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

Background: Anabolic androgenic steroids (AAS) are sometimes used by power athletes to improve performance by increasing muscle mass and strength. Recent bioptical data have shown that in athletes ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...